Rubius delays first clinical readout, as crowded PKU field marches on

Those waiting for the first look at human data from Rubius will have to be patient for a few more months. On Thursday, the Cambridge, Massachusetts-based biotech delayed the timeline for its first clinical readout to early 2020, admitting the trial has yet to dose its first patient.